Nerve growth factor (NGF) has an important role in regulating sympathetic neuron survival and target field innervation during development. Here we show that glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR), a member of the TNF superfamily, and its ligand (GITRL) are co-expressed in mouse sympathetic neurons when their axons are innervating their targets under the influence of target-derived NGF. In culture, GITRL enhanced NGF-promoted neurite growth from neonatal sympathetic neurons, and preventing GITR-GITRL interaction in these neurons or knocking down GITR inhibited NGF-promoted neurite growth without affecting neuronal survival. Tnfrsf18 2/2 (Gitr) neonates have reduced sympathetic innervation density in vivo compared with Gitr 1/1 littermates. GITR activation is required for the phosphorylation of extracellular signal-regulated kinases 1 and 2 by NGF that is necessary for neurite growth. Our results reveal a previously unknown signaling loop in developing sympathetic neurons that is crucial for NGF-dependent axon growth and target innervation.
The growth and guidance of axons to their targets and the terminal arborization of axons in their targets are controlled by numerous locally acting and diffusible signaling molecules. These molecules are derived from a wide variety of cells and bind to receptors on advancing axons to influence growth rate, direction and branching 1, 2 . Sympathetic neurons of the developing superior cervical ganglion (SCG) are an extensively studied, experimentally tractable model for analyzing the molecular basis of axonal growth and target innervation, as well as other aspects of neuronal development. Several secreted factors have been implicated in promoting the growth of sympathetic axons, including NGF, neurotrophin-3 (NT-3), artemin and hepatocyte growth factor (HGF) 3 . Of these, the most extensively studied and best understood is NGF, which is necessary for the innervation and terminal sprouting of sympathetic axons in many distal targets 4, 5 . In addition, target-derived NGF has a well-established role in promoting and regulating sympathetic neuron survival during development 6 .
To identify other candidate signaling molecules involved in sympathetic neuron development, we carried out a PCR screen for the expression of known families of receptors in the developing SCG. Among the receptor transcripts expressed at high levels was that of GITR. GITR, like the p75 neurotrophin receptor, is a member of the tumor necrosis factor receptor (TNFR) superfamily, but unlike p75 NTR , GITR lacks a cytoplasmic death domain. GITR and its specific ligand, GITRL, are expressed in many tissues, but have only been functionally characterized in the immune system, where they are involved in regulating innate and acquired immune responses 7 . Depending on the cellular context, GITR activates or inhibits multiple intracellular signaling pathways, of which the two most well described are the NF-kB 8, 9 and MAP kinase signaling pathways 10 .
Here we present data examining the functional significance of GITR expression in developing sympathetic neurons and show that GITRL-GITR signaling acting in a costimulatory manner is crucial during the immediate postnatal period for NGF-dependent axonal growth, branching and target innervation.
RESULTS

Co-expression of GITR and GITRL in sympathetic neurons
Quantification of GITR mRNA levels in the SCG at intervals throughout the period of target field innervation and naturally occurring neuron death revealed a significant increase from embryonic day 15 (E15) to a peak at postnatal day 1 (P1), followed by a decline to P5 (P o 0.001, Fig. 1a) . To explore the possibility of local GITR signaling in the SCG, we quantified the level of GITRL mRNA over the same age range and found a very similar developmental profile to that of GITR mRNA (Fig. 1b) . Thus, transcripts for both receptor and ligand are expressed in the developing SCG with the highest levels appearing shortly after the onset of naturally occurring neuronal death in the SCG, when sympathetic axons have begun to innervate and branch extensively in their targets 4, 11, 12 . To determine which kinds of cells in the SCG express GITR and GITRL, we used immunocytochemistry to localize these proteins in dissociated SCG cultures established from P1 mice. Triple-labeled preparations, in which neurons were positively identified with antibodies to b-III tubulin and cell nuclei were labeled with the fluorescent nuclear marker DAPI, revealed that both GITR and GITRL were expressed in all neurons. Non-neuronal cells showed little or no immunoreactivity for either ligand or receptor (Fig. 1c) . Likewise, immunohistochemistry revealed that GITR and GITRL colocalized with the neuronal markers TrkA and b-III tubulin in sections of P0 SCG (Fig. 1d,e) .
GITRL-GITR signaling is required for NGF-promoted growth
The co-expression of GITR and GITRL in neonatal SCG neurons raised the possibility of GITRL-GITR signaling in or between these neurons. To investigate the potential significance of GITRL-GITR signaling, we used three approaches to inhibit GITRL-GITR signaling in cultured P1 SCG neurons: expression of antisense GITR RNA in the neurons to reduce GITR production, treatment of the neurons with a GITR-IgG fusion protein that binds GITRL and prevents it from interacting with GITR extracellularly, and comparative studies of neurons obtained from wild-type and GITR-deficient mice. The neurons were grown at low density in defined, serum-free medium containing NGF to sustain their survival. Antisense GITR RNA was expressed in SCG neurons by ballistic transfection with gold particles that were coated with an antisense GITR pcDNA3.1 expression plasmid 2 h after plating. Neurons transfected with this plasmid, but not control transfected neurons (transfected with a pcDNA3.1 plasmid contained a random nucleotide insert), showed a pronounced decrease in GITR immunoreactivity 24 h after plating (Fig. 2a) . Sholl analysis, which provides a graphic illustration of neurite length and branching with distance from the cell body, showed that antisense GITR (Fig. 2b) and GITR-IgG (Fig. 2c) caused very substantial decreases in NGF-promoted neurite growth compared with control transfected and control IgG treatedneurons, respectively. Furthermore, antisense GITR caused an 83% reduction in neurite length and a 78% reduction in branching, and GITR-IgG caused a 42% reduction in neurite length and a 31% reduction in branching (data not shown). Neither antisense GITR nor GITR-IgG significantly affected NGF-promoted survival (P 4 0.05, Fig. 2d) .
To investigate the effect of genetic deletion of GITR on neurite growth, we crossed Gitr +/À mice to generate Gitr +/+ , Gitr +/À and Gitr À/À pups. Separate SCG cultures were established from each pup, and neuronal survival and neurite arbor size were quantified after a 24-h incubation with NGF. GITR deletion had no significant effect on the number of neurons surviving with NGF (P 4 0.05, Fig. 2e ), but caused a very substantial decreases in neurite length (Fig. 2f) , branching (Fig. 2i ). These findings demonstrate that NGF-promoted neurite growth from neonatal SCG neurons, but not the survival of these neurons, is crucially dependent on the GITRL-GITR interaction.
Although the GITR knockdown and GITR deletion experiments cannot distinguish between paracrine and autocrine GITRL-GITR signaling in these cultures, the GITR-IgG experiments suggest that GITRL-GITR signaling operates via an autocrine route. In these latter experiments, the GITRL-GITR interaction was blocked at the level of individual neurons, as the neurons were plated at such a low density as to eliminate any direct contact between their neurite arbors. The immunohistochemical staining pattern of GITRL in vivo is also consistent with autocrine GITRL-GITR signaling in sympathetic neurons. Although GITRL and GITR are clearly co-expressed in neurons of the SCG (Fig. 1d,e) , GITRL immunoreactivity was undetectable in intermediate and distal SCG targets such as cranial arteries, nasal mucosa and iris (data not shown).
Activation of GITR increases NGF-promoted neurite growth
To determine whether NGF-dependent neurite growth is maximally stimulated by endogenous GITRL-GITR signaling in SCG neurons, we studied the effect of enhancing GITR activation in these neurons. This was done by either overexpressing GITRL or by activating GITR with a soluble GITRL-IgG fusion protein. We found that GITRL-IgG was a potent costimulator of T lymphocyte proliferation in the presence of suboptimal concentrations of antibody to CD3, but was ineffective on lymphocytes from Gitr -/-mice ( Supplementary Fig. 1 online) . Sholl analysis showed that GITRL overexpression (P o 0.001, Fig. 3a ) and GITRL-IgG treatment (P o 0.001, Fig. 3b ) promoted significant increases in the size and complexity of the neurite arbors of SCG neurons grown with NGF, without significantly affecting survival (data not shown, P 4 0.05). GITRL-IgG failed to enhance neurite growth from SCG neurons of GITR -/-mice ( Supplementary Fig. 2 online), confirming that GITRL-IgG acts specifically via GITR in neurons. Our finding that GITR overexpression did not enhance neurite growth from NGF-supported SCG neurons (data not shown) implies that the endogenous level of GITR expression is not limiting for GITRL-GITR signaling in these neurons. Rather, it appears that the endo genous level of GITRL synthesis or the subsequent events that lead to its interaction with GITR, governs the degree of GITRL-GITR signaling in SCG neurons.
To investigate whether GITRL-GITR signaling is capable of promoting neurite growth independently of NGF, we cultured SCG neurons with the broad-spectrum, irreversible caspase inhibitor Boc-D-FMK to prevent the neurons from dying in the absence of NGF and treated them with GITRL-IgG. The smaller neurite arbors of these NGF-deprived neurons were not significantly affected by GITRL-IgG (P 4 0.05, Fig. 3c ), suggesting that enhanced GITRL-GITR signaling cannot promote neurite growth alone. GITRL-IgG did not affect the number of neurons surviving with or without NGF (data not shown), confirming that GITRL-GITR signaling does not affect sympathetic neuron survival.
To determine whether the effects of GITR signaling are specific for NGF-promoted neurite growth from SCG neurons, we carried out additional experiments on these and other neurons from P1 mice. Neither GITR-IgG nor GITRL-IgG affected HGF-promoted neurite growth from SCG neurons (data not shown). In contrast to SCG neurons, the sensory neurons of the trigeminal and nodose ganglia express only low levels of GITR, and overexpression of GITRL or antisense GITR had no effect on NGF-promoted and brainderived neurotrophic factor-promoted neurite growth, respectively (data not shown).
GITRL-GITR influences growth over a developmental window
To determine whether GITRL-GITR signaling facilitates neurite growth throughout the period of development when SCG neurons respond to NGF or whether its influence is restricted to a particular stage of development, we studied the effects of GITRL overexpression and GITR-IgG on neurite growth from SCG neurons that were cultured with NGF at several developmental ages. These experiments revealed that, in P1 and P3 cultures, GITRL overexpression significantly increased and GITR-IgG significantly decreased NGF-promoted neurite growth (P o 0.001). However, neither GITRL overexpression (Fig. 4a) nor GITR-IgG (Fig. 4b) affected the extent of NGF-promoted neurite growth in E18 and P5 cultures. To see whether GITRL responsiveness could be conferred at these latter ages, we transfected E18 and P5 SCG neurons with both GITR and GITRL plasmids; however, we found no differences in the extent of neurite outgrowth from these neurons compared with control transfected neurons (data not shown). This suggests that the developmental window of the effects of GITR signaling on NGF-promoted neurite growth is not simply governed by developmental changes in the expression of receptor and ligand.
Together these results show that GITRL-GITR signaling exerts its effects on neurite growth during a narrow window of development in Figure 3 Effect of enhancing GITRL-GITR signaling on neurite growth of SCG neurons grown with and without NGF. (a) The effect of overexpressing GITRL on NGF-promoted neurite growth. We transfected P1 SCG neurons with a YFP expression plasmid and with either a plasmid expressing GITRL or an empty control plasmid (Cont) 2 h after plating. The Sholl plots for GITRL-overexpressing and control neurons are shown after 24-h incubation with 10 ng ml -1 NGF. GITRL overexpression caused a 90% increase in neurite length and a 40% increase in the number of branch points (significant in both cases, P o 0.001). (b) The effect of activating GITR with a soluble GITRL-IgG agonist on NGF-promoted neurite growth. P1 SCG neurons were plated in medium containing 10 ng ml -1 NGF with 1 mg ml -1 of either GITRL-IgG or control IgG (antibody to b-III tubulin). The Sholl plots for GITRL-IgG-treated and control neurons are shown after 24-h incubation. GITRL-IgG caused a 37% increase in neurite length and a 24% increase in the number of branch points (significant in both cases, P o 0.001). (c) The effect of GITRL-IgG on neurite growth from P1 SCG neurons grown without NGF. The neurons were incubated with 1 mg ml -1 of either GITRL-IgG or control IgG (antibody to b-III tubulin) in medium containing the caspase inhibitor Boc-D-FMK. The Sholl profiles after 24-h incubation are shown. The mean ± s.e.m. of at least 150 neurons in each condition from at least three independent experiments is shown for each dataset. the immediate postnatal period. Thus, GITRL-GITR signaling affects neurite growth and branching during the period of development when SCG axons are growing and branching in their targets under the influence of target-derived NGF. Because the neurites in shortterm SCG cultures, such as those used in our study, are exclusively axons rather than dendrites 13 , it is reasonable to assume that GITRL-GITR signaling regulates axonal growth and branching during this period of development.
GITR is required for sympathetic innervation in vivo
To determine whether our in vitro observations are physiologically relevant for sympathetic innervation in vivo, we compared sympathetic innervation density in Gitr-null mice and their wild-type littermates. The iris and the nasal mucosa normally receive a dense sympathetic innervation from the SCG by axons that can be easily identified and quantified by immunostaining for tyrosine hydroxylase. At P1, there were marked, highly significant reductions in sympathetic innervation density in both targets in Gitr À/À mice and clear gene-dosage effects in Gitr +/À mice (P o 0.001, Fig. 5a,b) . To determine whether this in vivo defect in sympathetic innervation was still evident beyond the period of development when GITRL-GITR signaling is required for NGFpromoted sympathetic axon growth in vitro, we compared sympathetic innervation density in the nasal mucosa of Gitr À/À mice and wild-type littermates at P10. This analysis ( Supplementary Fig. 3 online) revealed a reduction in the tyrosine hydroxylase immunofluorescence of Gitr À/À mice compared with Gitr +/+ mice (41% reduction) that was very similar to that observed in P1 mice (42% reduction), indicating that the innervation deficit evident at P1 does not recover with age.
To exclude the possibility that decreased tyrosine hydroxylase immunofluorescence in the sympathetic targets of Gitr À/À mice was not simply a result of down-regulation of tyrosine hydroxylase expression in the innervating neurons, we quantified tyrosine hydroxylase mRNA levels and tyrosine hydroxylase immunofluorescence in the SCG of these mice and wild-type littermates. These studies revealed no significant differences (P 4 0.05) in the levels of either tyrosine hydroxylase mRNA or tyrosine hydroxylase-immunofluorescence intensity in the ganglia of all three genotypes ( Supplementary  Fig. 3 ), supporting the idea that the reduction in tyrosine hydroxylase immunofluorescence in the sympathetic targets of Gitr-null mice is the result of a reduction in the number of sympathetic axons in these targets. Reduced sympathetic innervation density could not only result from defective axonal growth and branching, but from a decrease in the size of the innervating population of neurons. To investigate if excessive loss of SCG neurons in Gitr-null mice contributes to the innervation defect, we counted the number of neurons in the SCG of Gitr +/+ , Gitr +/À and Gitr À/À mice at P1 and found no significant differences (P 4 0.05; Supplementary Fig. 3 ). Taken together, these results demonstrate that GITRL-GITR signaling plays a crucial role in the establishment of sympathetic innervation, but is not required for the survival of developing sympathetic neuron in vivo. These in vivo findings are entirely consistent with our demonstration that GITRL-GITR signaling is selectively required for the effects of NGF on axon growth, but not survival of neonatal SCG neurons in vitro.
Our in vitro studies suggest that there is a selective requirement for GITRL-GITR signaling in NGF-promoted axonal growth from sympathetic, but not sensory, neurons. To ascertain if a similar selectivity operates in vivo, we quantified the innervation density of the irises of P1 Gitr +/+ and Gitr À/À mice by calcitonin gene-related peptide (CGRP) + axons from NGF-dependent sensory neurons of the trigeminal ganglion. Quantification of CGRP immunoreactivity revealed no significant differences in intensity between Gitr +/+ and Gitr À/À mice (P 4 0.05; Supplementary Fig. 3 ), demonstrating that sensory innervation is established independently of GITRL-GITR signaling.
GITR facilitates NGF-promoted activation of ERK1 and ERK2
To elucidate the molecular mechanism underlying the selective influence of GITRL-GITR on NGF-promoted axonal growth, we explored potential common links in intracellular signaling. Among these is MAP kinase signaling, which has been shown to contribute to NGF-promoted neurite growth in PC12 cells and sympathetic neurons [14] [15] [16] . Because GITR acts as a co-accessory molecule in facilitating CD3-induced activation of the MAP kinases extracellular signal-regulated kinase 1 (ERK1) and ERK2 in T lymphocytes 10 , we asked whether GITR has a similar role in NGF-induced ERK1/ERK2 activation in SCG neurons. NGF induced a robust activation of ERK1/ ERK2 in P1 SCG neurons that peaked between 45 and 60 min after NGF treatment (Fig. 6a) . To determine whether endogenous GITRL-GITR signaling is required for NGF-induced ERK1/ERK2 activation, we compared NGF-induced ERK activation in SCG neurons obtained from P1 Gitr-null mice and their wild-type littermates. Compared with wildtype SCG neurons, ERK1/ERK2 activation was reduced in the neurons of Gitr +/À mice and was almost eliminated in neurons from Gitr À/À mice (Fig. 6b) . This suggests that GITRL-GITR signaling facilitates NGF-induced ERK1/ERK2 activation in neonatal sympathetic neurons. To assess the importance of ERK1/ERK2 activation in NGF-promoted axonal growth in our in vitro procedure, we studied the effect of U0126, a selective pharmacological blocker of mitogen-activated protein kinase kinases 1 and 2, the kinases that phosphorylate ERK1/ERK2. This compound caused a substantial decrease in the size and complexity of the neurite arbors of P1 SCG neurons grown with NGF (Fig. 6c) without affecting the survival of these neurons (data not shown). These results suggest that the facilitation of NGF-induced ERK1/ERK2 activation by GITR is central to the mechanism underlying the effects of endogenous GITRL-GITR signaling on NGF-induced axonal growth.
GITR enhances axonal growth by increasing ERK activation
To further investigate the MAP kinase link between GITRL-GITR signaling and NGF-promoted axon growth, we examined the role of ERK1/ERK2 activation in mediating the increase in NGF-promoted axonal growth produced by GITRL-IgG. To determine whether GITRLIgG treatment increases ERK1/ERK2 activation in SCG neurons and whether this depends on the presence of NGF, we incubated P1 SCG neurons with and without NGF for 12 h before exposing the neurons to GITRL-IgG for different times, and studied ERK1/ERK2 phosphorylation by western blotting. The initial period of culture before GITRLIgG treatment permitted phospho-ERK1/ERK2 levels to fall to basal levels so that any subsequent increase could be clearly observed. Treatment of NGF-supplemented neurons with GITRL-IgG caused a clear increase in ERK1/ERK2 activation that was maximal by 30 min (Fig. 7a) . Neurons that were incubated without NGF and were sustained with caspase inhibitors before GITRL-IgG treatment did not have detectable phospho-ERK1/ERK2 at any time point examined (Fig. 7b) . These results show that GITRL-IgG increases NGF-promoted ERK1/ERK2 activation, but is incapable of activating ERK1/ERK2 in the absence of NGF.
To investigate whether the enhanced ERK1/ERK2 activation brought about by GITRL-IgG in NGF-supplemented cultures is responsible for (Calbiochem) for 2 h, followed by the addition of 10 ng ml -1 NGF. We labeled the neurons 24 h later with calcein-AM, and images were digitally acquired for neurite arbor analysis. The Sholl plots for U0126-treated and U0124-treated (control) neurons are shown. U0126 caused a 44% decrease in neurite length and a 38% decrease in the number of branch points (significant in both cases, P o 0.01). These results are derived from the grouped data of three independent experiments.
the increase in NGF-promoted axonal growth, we examined whether U0126 could prevent this increase in growth. Because U0126 reduces NGF-promoted growth if added before or at the time that neurons are exposed to NGF (Fig. 6c) , we first grew the neurons with NGF for 4 h to allow phospho-ERK1/ERK2 levels to return to a low level before treating the neurons with U0126 and GITRL-IgG, which allowed us to selectively study the effect of GITRL-IgG-enhanced ERK1/ERK2 activation on neurite growth. In these experiments, the enhanced axonal growth and branching produced by GITRL-IgG was completely abolished by U0126 (Fig. 7c-f ). These results demonstrate that the enhanced ERK1/ERK2 activation brought about by stimulating GITR with exogenous ligand is responsible for the increase in NGF-promoted axonal growth. Taken together, the above findings indicate that GITR acts as a coaccessory molecule in NGF-induced ERK activation in neonatal sympathetic neurons in much the same way that it does in CD3-stimulated T cells, and that this mechanism underlies the selective effect of GITRL-GITR signaling on axonal growth. GITR ligation in T cells also causes robust activation of NF-kB 8 . Although NF-kB has been implicated in promoting neurite growth from sensory neurons 17, 18 , we have found, using a sensitive NF-kB reporter, that GITR ligation does not activate NF-kB in SCG neurons (data not shown), suggesting that GITR does not enhance NGF-promoted neurite growth in these neurons by activating NF-kB.
DISCUSSION
We have shown that the GITRL-GITR interaction in developing sympathetic neurons is crucial for NGF-promoted axonal growth and target innervation in the immediate postnatal period when sympathetic axons are ramifying in their distal targets under the influence of target-derived NGF. Inhibiting the GITRL-GITR inter action in cultured neonatal sympathetic neurons by antisense knockdown of GITR, targeted deletion of GITR or blocking the interaction between GITRL and GITR with a soluble GITR-IgG decoy substantially reduced the ability of NGF to promote neurite growth from these neurons without affecting their survival. Furthermore, the highly significant reduction in sympathetic innervation density in GITRdeficient neonates and the clear gene-dosage effect in heterozygous mice indicate the importance of GITR signaling for the proper establishment of sympathetic innervation in vivo. These findings not only reveal the existence of a previously unknown mechanism for regulating NGF-dependent target innervation, but provide the first evidence that GITRL-GITR interactions have important functions outside of the immune system.
The co-expression GITR and GITRL in sympathetic neurons and our finding that blocking GITRL-GITR interaction at the level of individual neurons with GITR-IgG inhibits NGF-promoted neurite growth indicate that GITRL-GITR signaling operates via an autocrine mechanism in developing sympathetic neurons. Autocrine signaling has previously been demonstrated in sympathetic neuroblasts. Studies using function-blocking antibodies to HGF in low-density cultures of mouse SCG neuroblasts have shown that a HGF/Met autocrine loop promotes the differentiation of these neuroblasts into neurons 19 . HGF also enhances neurite growth from mouse SCG neurons later in development, either alone or in the presence of NGF, but at no stage during fetal or postnatal development or in the adult do antibodies to HGF substantially reduce neurite arbor size in low-density cultures 15, 19 , suggesting that HGF may be involved in regulating the growth of SCG axons independently of NGF throughout life. Although antibodies to HGF has been reported to reduce neurite network complexity in dense cultures of postnatal rat SCG neurons 20 , it is unclear whether this was a result of changes in arbor size or neurite fasciculation, as individual neurite arbors were not analyzed. Although we suggest that GITRL-GITR signaling most likely operates by an autocrine route in sparse neuronal cultures, this does not preclude the possibility of paracrine GITRL-GITR signaling in vivo influencing axonal growth in addition to the autocrine GITRL-GITR rheostat. Indeed, our experiments with GITRL overexpression and GITRL-IgG have shown that NGFstimulated sympathetic neurons have the capacity to respond to enhanced GITR activation with increased neurite growth. However, we have not detected GITRL immunoreactively in the intermediate and distal targets of SCG neurons at the stage when GITR signaling affects sympathetic innervation density.
The effect of GITRL on sympathetic axon growth shows several distinctive features that distinguish it from the effects of other factors on sympathetic axon growth. Although HGF, macrophage-stimulating protein, glial-derived neurotrophic factor, neurotrophin-3 and NGF promote the growth of sympathetic axons at particular stages of development in vitro, they also promote sympathetic neuron survival to varying extents and are each able to exert these effects independently of the presence of other factors 15, 19, [21] [22] [23] . In contrast, GITRL-GITR interaction only influences neurite growth in the presence of NGF and has no effect on the survival of sympathetic neurons either in the presence or absence of NGF in vitro. Likewise, the number of SCG neurons in vivo is not reduced in Gitr À/À mice. GITRL-GITR signaling appears to exert its selective effect on NGFpromoted axonal growth from neonatal SCG neurons by facilitating a key step in the NGF signaling cascade, ERK1/ERK2 activation, that is selectively required for NGF-promoted axonal growth, but not for survival. NGF-promoted ERK1/ERK2 phosphorylation was attenuated in neurons from Gitr +/À mice, and was almost eliminated in neurons from Gitr À/À mice. Although GITRL-IgG enhanced NGF-promoted ERK1/ERK2 phosphorylation, GITRL-IgG did not activate ERK1/ ERK2 in the absence of NGF. This effect of GITR signaling on NGFpromoted ERK1/ERK2 activation mirrors the co-accessory role of GITR in CD3-stimulated T lymphocytes. CD3 promotes ERK1/ERK2 activation in T cells, which in turn mediates a robust proliferative response 10 . Costimulation of T cells with antibody to CD3 and GITRL enhances ERK1/ERK2 activation and increases proliferation 10 , but activation of GITR in the absence of antibody to CD3 neither increases ERK1/ERK2 activation (C.R., unpublished data) nor induces any proliferative response ( Supplementary Fig. 1 ). In addition to GITR, several other members of the TNFR superfamily, including CD30, CD40 and RANK, have been shown to act as co-accessory molecules in facilitating ERK1/ERK2 phosphorylation in the immune system 24, 25 . Multiple members of the TNFR superfamily are also expressed in the SCG with different developmental time courses (G.W.O'K., unpublished data). In future work, it will be interesting to ascertain whether any of these TNFR members have a similar role to GITR in axonal growth at stages before and after the period of development at which GITR activation is crucial for NGF-promoted axonal growth.
NGF was discovered over half a century ago by its ability to promote axonal growth, and is the model target-derived neurotrophic factor on which the neurotrophic theory is based 26 . The discovery of a previously unknown signaling loop that is essential for the ability of NGF to promote axonal growth has revealed a new and completely unexpected regulatory element in target field innervation in the developing sympathetic nervous system. Preliminary expression studies have revealed that sympathetic neurons are not the only neurons to express GITR and GITRL. In future work, it will be important to ascertain how extensively GITRL-GITR signaling regulates the growth of neural processes in the nervous system.
METHODS
Real-time PCR quantification of mRNA levels. Total RNA was isolated with the RNeasy Mini extraction kit (Qiagen) from dissected SCG. The RNA was reverse transcribed for 1 h at 37 1C with StrataScript RT (Stratagene) in a 40-ml reaction containing the manufacturer's buffer with 5 mM dNTPs (Stratagene) and 10 mM random hexamers (Amersham). We amplified 3-ml aliquots of the reverse transcriptase reactions in a 25-ml reaction volume using the Brilliant QPCR core reagent kit (Stratagene). Each reaction mixture consisted of 1Â PCR buffer, 3 mM MgCl 2 , 300 pmol primers, 0.4 mM dNTPs, 1 U Taq, 1Â reference dye and 1 U SYBR green (Molecular Probes). The respective forward and reverse primers for real-time PCR were: GITR, 5¢-AGG TCA GCC GAG TGT AGT TG-3¢ and 5¢-GCA GCA GCA GCA GCG AGT GTT GTT G-3¢; GITRL, 5¢-TGG CTC TGT TAC TGA TGC TG-3¢ and 5¢-AGT GAG GTT TGG GAG ATG TC-3¢; tyrosine hydroxylase, 5¢-AAG GAA AGT GTC AGA GTT G-3¢ and 5¢-ACC CTG CTT GTA TTG GAA-3¢; GAPDH, 5¢-TCC CAC TCT TCC ACC TTC-3¢ and 5¢-CTG TAG CCG TAT TCA TTG TC-3¢. PCR was carried out with a Mx3000P (Stratagene) for 45 cycles of 95 1C for 30 s, 54 1C (for GITR and tyrosine hydroxylase) or 51 1C (for GITRL and GAPDH) for 1 min, and 72 1C for 30 s. A melting curve was obtained to confirm that the SYBR green signal corresponded to a unique and specific amplicon. Standard curves were generated for every real-time PCR run by using serial threefold dilutions of a reverse-transcribed RNA extract from an E13 whole mouse embryo.
Neuron cultures. Dissociated cultures of SCG neurons were set up from E18, P1, P3 and P5 CD1 mice or from P1 Gitr +/+ , Gitr +/À and Gitr À/À C57BL/6 pups and grown in defined medium on a poly-ornithin/laminin substratum as previously described 27, 28 . The results obtained in cultures established from both mouse strains are comparable because the SCG of C57BL/6 and CD1 mice express similar levels of GITR and show identical responses to GITR-IgG and GITRL-IgG (data not shown). All animal work was approved under the 1986 Animal Procedures Act with personal and project licenses granted by the Home Office, UK. Furthermore, this work was approved by the Cardiff University Ethical Review Board for Animal Research.
Gold microcarrier preparation and ballistic transfection of cultured neurons was carried out using a hand-held gene gun (BioRad) as previously described 17 . Neuronal survival was quantified as previously described 17, 18 . The neurite arbors of transfected neurons were visualized by expression of yellow fluorescent protein (YFP). In nontransfection experiments, neurite arbors were labeled with the fluorescent dye calcein-AM (Invitrogen) at the end of the experiment. For every condition in each experiment, images of at least 50 neurons were digitally acquired by confocal microscopy and analyzed to obtain total neurite length, number of branch points and Sholl profiles 29 as previously described 17, 18 . Pair-wise comparisons were made using Student's t-test. For multiple comparisons, ANOVA was carried out, followed by Fisher's post hoc test.
Immunocytochemistry. Cultures were fixed in ice-cold methanol, washed with phosphate-buffered saline (PBS) and blocked with 5% BSA in PBS. The cells were incubated overnight with primary antibody in 1% BSA at 4 1C. We used antibody to b-III tubulin (1:1,000, Promega), GITR (1:200, Chemicon), GITRL (1:100, R&D Systems) and YFP (1:1,000, Chemicon) as the primary antibodies. After washing, the cells were incubated with the appropriate secondary antibody (1:500, Alexa-Fluor, Invitrogen) and were counterstained with DAPI (Chemicon).
Quantification of neuron number in the SCG. Estimates of the numbers of neurons in the SCG of P1 Gitr +/+ , Gitr +/À and Gitr À/À pups were carried out by stereological analysis of serial section as previously described 30 .
Quantification of the sympathetic innervation of SCG targets. The eyes and noses of P1 Gitr +/+ , Gitr +/À and Gitr À/À littermates were fixed in 4% paraformaldehyde for 24 h and were cryoprotected in 30% sucrose before being frozen. We cut 15-mm serial sections at right angles to the visual axis. The sections were mounted onto polylysine-coated slides (BDH), blocked with 10% normal goat serum containing 0.1% Triton X-100 in 10 mM PBS for 1 h at 18-22 1C, and then incubated for 18 h at 4 1C with a rabbit polyclonal antibody to tyrosine hydroxylase (Chemicon), diluted 1:200 in PBS with 1% normal goat serum. The sections were washed three times in PBS before being incubated with the secondary antibody, goat antibody to rabbit (1:500, Alexa-Fluor, Invitrogen). All sections were counterstained with DAPI (Chemicon). For the iris, four images were digitally acquired from sections passing through the iris, each one from a different quadrant of the iris. For the nasal mucosa, every third section beginning from the tip of the nose and extending caudally was imaged. The outline of the iris and nasal mucosa in these images was traced using Adobe Photoshop 7. The total iris and nasal mucosa area and the area containing tyrosine hydroxylase-positive fibers were estimated by automated pixel counts, and the ratio tyrosine hydroxylase-positive area to total iris area was calculated as a percentage. Six eyes and three noses for each genotype were sectioned and analyzed before the genotypes were ascertained so as to avoid any sampling bias.
Western blotting. Western blotting was carried out using the BioRad TransBlot (BioRad) as previously described 18 , using antibody to phospho-Erk1/2 (1:1,000, Cell Signaling), antibody to total Erk (1:1,000, Cell Signaling) or antibody to b-III tubulin (1:10,000, Promega) as the primary antibodies, which were detected with the appropriate peroxidase-linked secondary antibodies (1:2,000, Promega) and ECL-plus (Amersham).
Note: Supplementary information is available on the Nature Neuroscience website.
